DBV Technologies Analyst Price Targets

Wall Street analyst price targets and consensus rating for DBV Technologies (DBVT).

Price Target Range — 10 Quarters

Analyst Consensus — 7 Analysts

3S.Buy

3Buy

1Sell

Consensus RatingMarket Outperform# Analysts7Avg. Consensus PT$26Upside to Avg. PT+76.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jun 30, 2026	Citizens	Jonathan Wolleben	PT Raise	Market Outperform	$47→$55
May 4, 2026	Guggenheim	Yatin Suneja	Maintained	Buy	$51
May 1, 2026	Citizens	Jonathan Wolleben	PT Raise	Market Outperform	$47→$55
Mar 27, 2026	Citizens	Jonathan Wolleben	PT Raise	Market Outperform	$45→$47
Mar 27, 2026	Guggenheim	Yatin Suneja	Maintained	Buy	$51
Dec 17, 2025	HC Wainwright & Co.	Andrew S. Fein	PT Raise	Buy	$35→$40
Dec 17, 2025	Cantor Fitzgerald	Kristen Kluska	PT Raise	Overweight	$42→$48
Dec 17, 2025	Citizens	Jonathan Wolleben	PT Raise	Market Outperform	$21→$45
Dec 17, 2025	Guggenheim	Yatin Suneja	PT Raise	Buy	$35→$51
Dec 15, 2025	HC Wainwright & Co.	Andrew S. Fein	PT Raise	Buy	$20→$35
Dec 15, 2025	Cantor Fitzgerald	Kristen Kluska	Initiate	Overweight	$42
Dec 3, 2025	Guggenheim	Yatin Suneja	Initiate	Buy	$35
Oct 29, 2025	HC Wainwright & Co.	Andrew S. Fein	PT Raise	Buy	$16→$20
Jun 26, 2025	JMP Securities	Jonathan Wolleben	Maintained	Market Outperform	$21
May 29, 2025	Goldman Sachs	Rajan Sharma	Reinstates	Sell	$7
May 27, 2025	JMP Securities	Jonathan Wolleben	PT Raise	Market Outperform	$15→$21
May 5, 2025	HC Wainwright & Co.	Andrew Fein	PT Raise	Buy	$7→$16
May 1, 2025	JMP Securities	Steven Delaney	PT Raise	Market Outperform	$10→$15
Mar 4, 2025	Citizens Capital Markets	Jonathan Wolleben	Maintained	Market Outperform	$10
Jan 10, 2025	JMP Securities	Jonathan Wolleben	Maintained	Market Outperform	$10

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on DBV Technologies, Raises Price Target to $55

Citizens analyst Jonathan Wolleben maintains DBV Technologies (NASDAQ:DBVT) with a Market Outperform and raises the price target from $47 to $55.

Benzinga Newsdesk

PRO
Guggenheim Reiterates Buy on DBV Technologies, Maintains $51 Price Target

Guggenheim analyst Yatin Suneja reiterates DBV Technologies (NASDAQ:DBVT) with a Buy and maintains $51 price target.

Benzinga Newsdesk

PRO
Citizens Maintains Market Outperform on DBV Technologies, Raises Price Target to $55

Citizens analyst Jonathan Wolleben maintains DBV Technologies (NASDAQ:DBVT) with a Market Outperform and raises the price target from $47 to $55.

Benzinga Newsdesk

DBV Technologies Sets Stage For 'Swift' Success As Breakthrough Peanut Patch Nears FDA Submission

DBV Tech (DBVT) maintains progress with BLA submission for VIASKIN peanut patch in children. Analyst maintains Buy rating with $51 target.

Priya Nigam

PRO
Citizens Maintains Market Outperform on DBV Technologies, Raises Price Target to $47

Citizens analyst Jonathan Wolleben maintains DBV Technologies (NASDAQ:DBVT) with a Market Outperform and raises the price target from $45 to $47.

Benzinga Newsdesk

PRO
Guggenheim Reiterates Buy on DBV Technologies, Maintains $51 Price Target

Guggenheim analyst Yatin Suneja reiterates DBV Technologies (NASDAQ:DBVT) with a Buy and maintains $51 price target.

Benzinga Newsdesk

DBV Technologies SA

DBV Technologies Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on DBV Technologies, Raises Price Target to $55

PRO
Guggenheim Reiterates Buy on DBV Technologies, Maintains $51 Price Target

PRO
Citizens Maintains Market Outperform on DBV Technologies, Raises Price Target to $55

DBV Technologies Sets Stage For 'Swift' Success As Breakthrough Peanut Patch Nears FDA Submission

PRO
Citizens Maintains Market Outperform on DBV Technologies, Raises Price Target to $47

PRO
Guggenheim Reiterates Buy on DBV Technologies, Maintains $51 Price Target

People Also Watch

People Also Watch

Benzinga

Benzinga

DBV Technologies SA

DBV Technologies Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCitizens Maintains Market Outperform on DBV Technologies, Raises Price Target to $55

PROGuggenheim Reiterates Buy on DBV Technologies, Maintains $51 Price Target

PROCitizens Maintains Market Outperform on DBV Technologies, Raises Price Target to $55

DBV Technologies Sets Stage For 'Swift' Success As Breakthrough Peanut Patch Nears FDA Submission

PROCitizens Maintains Market Outperform on DBV Technologies, Raises Price Target to $47

PROGuggenheim Reiterates Buy on DBV Technologies, Maintains $51 Price Target

People Also Watch

People Also Watch

PRO
Citizens Maintains Market Outperform on DBV Technologies, Raises Price Target to $55

PRO
Guggenheim Reiterates Buy on DBV Technologies, Maintains $51 Price Target

PRO
Citizens Maintains Market Outperform on DBV Technologies, Raises Price Target to $55

PRO
Citizens Maintains Market Outperform on DBV Technologies, Raises Price Target to $47

PRO
Guggenheim Reiterates Buy on DBV Technologies, Maintains $51 Price Target